Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1963 1
1969 1
1974 2
1975 2
1976 6
1977 5
1978 4
1979 3
1980 6
1981 8
1982 9
1983 11
1984 9
1985 6
1986 5
1987 8
1988 8
1989 13
1990 9
1991 11
1992 16
1993 20
1994 18
1995 35
1996 26
1997 24
1998 24
1999 24
2000 24
2001 29
2002 32
2003 26
2004 26
2005 34
2006 32
2007 26
2008 31
2009 35
2010 36
2011 43
2012 48
2013 54
2014 74
2015 60
2016 58
2017 71
2018 75
2019 89
2020 95
2021 92
2022 91
2023 62
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

1,411 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Compton-North congenital myopathy"
Page 1
Genotype-phenotype correlations in recessive RYR1-related myopathies.
Amburgey K, Bailey A, Hwang JH, Tarnopolsky MA, Bonnemann CG, Medne L, Mathews KD, Collins J, Daube JR, Wellman GP, Callaghan B, Clarke NF, Dowling JJ. Amburgey K, et al. Orphanet J Rare Dis. 2013 Aug 6;8:117. doi: 10.1186/1750-1172-8-117. Orphanet J Rare Dis. 2013. PMID: 23919265 Free PMC article.
BACKGROUND: RYR1 mutations are typically associated with core myopathies and are the most common overall cause of congenital myopathy. ...The recent availability of genetic testing for the entire RYR1 coding sequence has led to a dramatic expansion in the ide …
BACKGROUND: RYR1 mutations are typically associated with core myopathies and are the most common overall cause of congenital
X-linked myotubular myopathy.
Lawlor MW, Dowling JJ. Lawlor MW, et al. Neuromuscul Disord. 2021 Oct;31(10):1004-1012. doi: 10.1016/j.nmd.2021.08.003. Neuromuscul Disord. 2021. PMID: 34736623 Free article. Review.
X-linked myotubular myopathy (XLMTM) is a severe congenital muscle disease caused by mutation in the MTM1 gene. ...The disease is classically defined by characteristic changes observed on muscle biopsy, including centrally located nuclei, myofiber hypotrophy, …
X-linked myotubular myopathy (XLMTM) is a severe congenital muscle disease caused by mutation in the MTM1 gene. ...The disease …
'Dusty core disease' (DuCD): expanding morphological spectrum of RYR1 recessive myopathies.
Garibaldi M, Rendu J, Brocard J, Lacene E, Fauré J, Brochier G, Beuvin M, Labasse C, Madelaine A, Malfatti E, Bevilacqua JA, Lubieniecki F, Monges S, Taratuto AL, Laporte J, Marty I, Antonini G, Romero NB. Garibaldi M, et al. Acta Neuropathol Commun. 2019 Jan 5;7(1):3. doi: 10.1186/s40478-018-0655-5. Acta Neuropathol Commun. 2019. PMID: 30611313 Free PMC article.
We named Dusty Core Disease (DuCD) the corresponding entity of congenital myopathy. Dusty cores had peculiar histological and ultrastructural characteristics compared to the other core diseases. DuCD muscle biopsies also showed nuclear centralization and type …
We named Dusty Core Disease (DuCD) the corresponding entity of congenital myopathy. Dusty cores had peculiar histological and …
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.
Karaa A, Bertini E, Carelli V, Cohen BH, Enns GM, Falk MJ, Goldstein A, Gorman GS, Haas R, Hirano M, Klopstock T, Koenig MK, Kornblum C, Lamperti C, Lehman A, Longo N, Molnar MJ, Parikh S, Phan H, Pitceathly RDS, Saneto R, Scaglia F, Servidei S, Tarnopolsky M, Toscano A, Van Hove JLK, Vissing J, Vockley J, Finman JS, Brown DA, Shiffer JA, Mancuso M; MMPOWER-3 Trial Investigators. Karaa A, et al. Neurology. 2023 Jul 18;101(3):e238-e252. doi: 10.1212/WNL.0000000000207402. Epub 2023 Jun 2. Neurology. 2023. PMID: 37268435 Free PMC article. Clinical Trial.
Primary efficacy endpoints included change from baseline to week 24 on the distance walked on the 6-minute walk test (6MWT) and total fatigue on the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA). Secondary endpoints included most bothersome symptom score
Primary efficacy endpoints included change from baseline to week 24 on the distance walked on the 6-minute walk test (6MWT) and total fatigu …
Effect of physical therapy treatment in infants treated for congenital muscular torticollis - a narrative review.
Bashir A, Amjad F, Ahmad A, Arooj A, Gilani SA. Bashir A, et al. J Pak Med Assoc. 2023 Jan;73(1):111-116. doi: 10.47391/JPMA.3852. J Pak Med Assoc. 2023. PMID: 36842018 Free article. Review.
To determine the effectiveness of physical therapy treatment in infants treated for congenital muscular torticollis, relevant articles published between 2011 and 2020 were located using electronic databases. ...The studies typically found significant statistical eff …
To determine the effectiveness of physical therapy treatment in infants treated for congenital muscular torticollis, relevant …
FXR1-related congenital myopathy: expansion of the clinical and genetic spectrum.
Mroczek M, Longman C, Farrugia ME, Kapetanovic Garcia S, Ardicli D, Topaloglu H, Hernández-Laín A, Orhan D, Alikasifoglu M, Duff J, Specht S, Nowak K, Ravenscroft G, Chao K, Valivullah Z, Donkervoort S, Saade D, Bönnemann C, Straub V, Yoon G. Mroczek M, et al. J Med Genet. 2022 Nov;59(11):1069-1074. doi: 10.1136/jmedgenet-2021-108341. Epub 2022 Apr 7. J Med Genet. 2022. PMID: 35393337 Free PMC article.
Muscle biopsy showed multi-minicores and type I fibre predominance with internalised nuclei. CONCLUSION: FXR1-related congenital myopathy is an emerging entity that is clinically recognisable. ...Our work broadens the phenotypic spectrum of FXR1-related congenita
Muscle biopsy showed multi-minicores and type I fibre predominance with internalised nuclei. CONCLUSION: FXR1-related congenital m
Recent advances in understanding congenital myopathies.
Ravenscroft G, Bryson-Richardson RJ, Nowak KJ, Laing NG. Ravenscroft G, et al. F1000Res. 2018 Dec 11;7:F1000 Faculty Rev-1921. doi: 10.12688/f1000research.16422.1. eCollection 2018. F1000Res. 2018. PMID: 30631434 Free PMC article. Review.
By definition, congenital myopathy typically presents with skeletal muscle weakness and hypotonia at birth. ...Thus, the congenital myopathy genes remaining to be discovered are predicted to be extremely rare causes of disease, which greatly ham …
By definition, congenital myopathy typically presents with skeletal muscle weakness and hypotonia at birth. ...Thus, the co
Nemaline Myopathy in Brazilian Patients: Molecular and Clinical Characterization.
Gurgel-Giannetti J, Souza LS, Yamamoto GL, Belisario M, Lazar M, Campos W, Pavanello RCM, Zatz M, Reed U, Zanoteli E, Oliveira AB, Lehtokari VL, Casella EB, Machado-Costa MC, Wallgren-Pettersson C, Laing NG, Nigro V, Vainzof M. Gurgel-Giannetti J, et al. Int J Mol Sci. 2022 Oct 9;23(19):11995. doi: 10.3390/ijms231911995. Int J Mol Sci. 2022. PMID: 36233295 Free PMC article.
Nemaline myopathy (NM), a structural congenital myopathy, presents a significant clinical and genetic heterogeneity. ...Clinically, the "typical" form was the more frequent and caused by mutations in the different NM genes. Phenotypic heterogeneity was obs
Nemaline myopathy (NM), a structural congenital myopathy, presents a significant clinical and genetic heterogeneity. .. …
Trouble at the junction: When myopathy and myasthenia overlap.
Nicolau S, Kao JC, Liewluck T. Nicolau S, et al. Muscle Nerve. 2019 Dec;60(6):648-657. doi: 10.1002/mus.26676. Epub 2019 Sep 10. Muscle Nerve. 2019. PMID: 31449669 Review.
Affected individuals have variable clinical phenotypes but typically display both a decrement on repetitive nerve stimulation and myopathic findings on muscle biopsy. Inherited causes include myopathies related to mutations in BIN1, DES, DNM2, GMPPB, MTM1, or PLEC and c
Affected individuals have variable clinical phenotypes but typically display both a decrement on repetitive nerve stimulation and myopathic …
Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T.
du Fay de Lavallaz J, Prepoudis A, Wendebourg MJ, Kesenheimer E, Kyburz D, Daikeler T, Haaf P, Wanschitz J, Löscher WN, Schreiner B, Katan M, Jung HH, Maurer B, Hammerer-Lercher A, Mayr A, Gualandro DM, Acket A, Puelacher C, Boeddinghaus J, Nestelberger T, Lopez-Ayala P, Glarner N, Shrestha S, Manka R, Gawinecka J, Piscuoglio S, Gallon J, Wiedemann S, Sinnreich M, Mueller C; BASEL XII Investigators. du Fay de Lavallaz J, et al. Circulation. 2022 Jun 14;145(24):1764-1779. doi: 10.1161/CIRCULATIONAHA.121.058489. Epub 2022 Apr 7. Circulation. 2022. PMID: 35389756 Free PMC article.
METHODS: We prospectively enrolled patients presenting with muscular complaints (2 weeks) for elective evaluation in 4 hospitals in 2 countries. ...CONCLUSIONS: In patients with active chronic SMD, elevations in cTnT concentrations are common and not attributable to cardia …
METHODS: We prospectively enrolled patients presenting with muscular complaints (2 weeks) for elective evaluation in 4 hospitals in 2 …
1,411 results